Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA7 | P43166 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | DRD4 | P21917 | 1/20 | 0.32 |
| ▸ | DRD3 | P35462 | 1/20 | 0.32 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | MMP9 | P14780 | 1/20 | 0.31 |
| ▸ | MMP12 | P39900 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12480744 | 0.87 | CA12 (0.32) | CA12CA1CA2CA7CA9 | |
| SCHEMBL3165171 | 0.82 | CA12 (0.31) | CA12CA1CA2CA7CA9 | |
| SCHEMBL12445315 | 0.80 | — | — | |
| SCHEMBL12445314 | 0.78 | — | — | |
| SCHEMBL19795474 | 0.78 | HSD17B10 (0.31) | — | |
| SCHEMBL12708525 | 0.76 | RECQL (0.33) | — | |
| SCHEMBL15132093 | 0.76 | — | — | |
| SCHEMBL19795489 | 0.76 | PTPN1 (0.33) | — | |
| SCHEMBL7402746 | 0.76 | MMP1 (0.35) | CA12CA1CA2CA7CA9 | |
| SCHEMBL15132094 | 0.74 | RECQL (0.32) | CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114497689-A | Lithium ion battery electrolyte and lithium ion battery | 张家港市国泰华荣化工新材料有限公司 | 2022-05-13 | — | — | CN | claimed |
| CN-113801019-A | Method for preparing poly-fluorobenzyl methyl ether | 沈阳中化农药化工研发有限公司 | 2021-12-17 | — | — | CN | disclosed |
| CN-107709506-B | Surface treating agent containing perfluoro (poly) ether group-containing silane compound | 大金工业株式会社 | 2020-06-16 | — | — | CN | disclosed |
| US-20120208223-A1 | FLUORESCENCE RESONANCE ENERGY TRANSFER ENZYME SUBSTRATES | GE HEALTHCARE AS (NO) | 2012-08-16 | — | — | US | disclosed |
| US-20090162838-A1 | FLUORESCENCE RESONANCE ENERGY TRANSFER ENZYME SUBSTRATES | KUMAR SHIV | 2009-06-25 | — | — | US | disclosed |
| EP-1738171-B1 | FLUORESCENCE RESONANCE ENERGY TRANSFER ENZYME SUBSTRATES | GE HEALTHCARE AS (NO) | 2009-04-08 | — | — | EP | disclosed |
| EP-1738171-A1 | FLUORESCENCE RESONANCE ENERGY TRANSFER ENZYME SUBSTRATES | GE Healthcare AS (NO) | 2007-01-03 | — | — | EP | disclosed |
| WO-2005108994-A1 | FLUORESCENCE RESONANCE ENERGY TRANSFER ENZYME SUBSTRATES | GE HEALTHCARE BIO-SCIENCES CORP. (US) | 2005-11-17 | — | — | WO | disclosed |
| WO-2000048993-A1 | ARYLAMINOALKYLAMIDES | NOVARTIS AG (CH) | 2000-08-24 | — | — | WO | disclosed |
| US-4990458-A | Macroreticular resin used as both adsorber and catalyst | MCMASTER UNIVERSITY (CA) | 1991-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120208223-A1 | FLUORESCENCE RESONANCE ENERGY TRANSFER ENZYME SUBSTRATES | DLD, DPYD, RNASE1 | CA12 1905/4885CA1 1451/4885CA2 2190/4885 |
| US-20090162838-A1 | FLUORESCENCE RESONANCE ENERGY TRANSFER ENZYME SUBSTRATES | DLD, DPYD, RNASE1 | CA12 1905/4885CA1 1451/4885CA2 2190/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.